Is There a Better Screening Tool for Cognitive Function and Employment Status in Patients With MS?May 27, 2015Multiple Sclerosis
Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1aMay 26, 2015Multiple Sclerosis
Conference News Update—Federation of American Societies for Experimental BiologyApril 29, 2015Multiple Sclerosis
Bright Spotty Lesions May Indicate Neuromyelitis Optica Spectrum DisorderNovember 21, 2014Multiple Sclerosis